Related Experiment Video
Updated: Jul 9, 2025
A Protocol for Explant Cultures of IDH1-mutant Diffuse Low-grade Gliomas
Published on: May 9, 2025
Differential metabolic alterations in IDH1 mutant vs. wildtype glioma cells promote epileptogenesis through
Darrian McAfee1, Mitchell Moyer1, Jaden Queen2
1Department of Neurosurgery, University of Maryland School of Medicine, Baltimore, MD, United States.
Abstract:
Glioma-related epilepsy (GRE) is a hallmark clinical presentation of gliomas with significant impacts on patient quality of life. The current standard of care for seizure management is comprised of anti-seizure medications (ASMs) and surgical resection. Seizures in glioma patients are often drug-resistant and can often recur after surgery despite total tumor resection. Therefore, current research is focused on the pro-epileptic pathological changes occurring in tumor cells and the peritumoral environment. One important contribution to seizures in GRE patients is metabolic reprogramming in tumor and surrounding cells. This is most evident by the significantly heightened seizure rate in patients with isocitrate dehydrogenase mutated (IDHmut) tumors compared to patients with IDH wildtype (IDHwt) gliomas. To gain further insight into glioma metabolism in epileptogenesis, this review compares the metabolic changes inherent to IDHmut vs. IDHwt tumors and describes the pro-epileptic effects these changes have on both the tumor cells and the peritumoral environment. Understanding alterations in glioma metabolism can help to uncover novel therapeutic interventions for seizure management in GRE patients.
Insights
Glioma-related epilepsy (GRE) seizures are often drug-resistant. Metabolic reprogramming in isocitrate dehydrogenase mutated (IDHmut) vs. IDH wildtype (IDHwt) gliomas influences seizure activity, offering new therapeutic targets.
Area of Science:
- Neuro-oncology
- Epileptology
- Cancer Metabolism
Background:
- Glioma-related epilepsy (GRE) significantly impacts patient quality of life.
- Current treatments like anti-seizure medications (ASMs) and surgery often fail due to drug-resistant seizures.
- Research is exploring pro-epileptic changes in tumor cells and the peritumoral environment.
Purpose of the Study:
- To compare metabolic reprogramming in IDH-mutated (IDHmut) versus IDH-wildtype (IDHwt) gliomas.
- To elucidate the pro-epileptic effects of these metabolic changes on tumor and peritumoral cells.
- To identify novel therapeutic targets for seizure management in GRE.
Main Methods:
- Review of existing literature on glioma metabolism and epileptogenesis.
- Comparative analysis of metabolic pathways in IDHmut and IDHwt gliomas.
- Examination of the impact of metabolic alterations on seizure activity.
Main Results:
- Metabolic reprogramming is a key contributor to seizures in GRE.
- IDHmut gliomas exhibit distinct metabolic profiles compared to IDHwt gliomas, correlating with heightened seizure rates.
- Altered glioma metabolism affects both tumor cells and the surrounding peritumoral environment, promoting epileptogenesis.
Conclusions:
- Understanding glioma cell metabolism is crucial for comprehending GRE.
- Metabolic differences between IDHmut and IDHwt gliomas offer insights into seizure mechanisms.
- Targeting metabolic pathways presents a promising avenue for developing novel therapies for GRE.
